HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pavel Stourac Selected Research

Natalizumab (Tysabri)

7/2021The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab.
5/2019The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pavel Stourac Research Topics

Disease

10Multiple Sclerosis
08/2023 - 12/2008
3Relapsing-Remitting Multiple Sclerosis
08/2023 - 07/2021
1Demyelinating Diseases (Demyelinating Disease)
08/2022
1Myelitis
08/2022
1Neuromyelitis Optica (Devic's Disease)
08/2022
1Fatigue
03/2022
1Lymphocytosis
07/2021
1Autoimmune Diseases (Autoimmune Disease)
10/2020
1Inflammation (Inflammations)
10/2020
1Progressive Multifocal Leukoencephalopathy
05/2019

Drug/Important Bio-Agent (IBA)

3Glatiramer Acetate (Copaxone)FDA Link
01/2023 - 08/2012
2Biomarkers (Surrogate Marker)IBA
08/2022 - 08/2021
2AntibodiesIBA
08/2022 - 05/2019
2Natalizumab (Tysabri)FDA Link
07/2021 - 05/2019
1Interferon beta-1aFDA Link
01/2023
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2023
1Myelin-Oligodendrocyte GlycoproteinIBA
08/2022
1AutoantibodiesIBA
08/2022
1Immunoglobulin G (IgG)IBA
08/2022
1InterferonsIBA
08/2021
1CTLA-4 AntigenIBA
10/2020
1Interferon-betaIBA
08/2012
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2008
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2008
1tau Proteins (tau Protein)IBA
12/2008

Therapy/Procedure

4Therapeutics
08/2023 - 07/2021
1Immunotherapy
08/2022